Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users
- PMID: 22490317
- PMCID: PMC3444141
- DOI: 10.1158/1055-9965.EPI-11-1178
Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users
Abstract
Background: The prevalence of tobacco use, both cigarette smoking and smokeless, including iqmik (homemade smokeless tobacco prepared with dried tobacco leaves mixed with alkaline ash), and of tobacco-related cancer is high in Alaskan Native people (AN). To investigate possible mechanisms of increased cancer risk we studied levels of nicotine and tobacco-specific nitrosamines (TSNA) in tobacco products and biomarkers of tobacco toxicant exposure in Southwestern AN people.
Methods: Participants included 163 cigarette smokers, 76 commercial smokeless tobacco, 20 iqmik, 31 dual cigarette smokers and smokeless tobacco, and 110 nontobacco users. Tobacco use history, samples of tobacco products used, and blood and urine samples were collected.
Results: Nicotine concentrations were highest in cigarette tobacco and TSNAs highest in commercial smokeless tobacco products. The AN participants smoked on average 7.8 cigarettes per day. Nicotine exposure, assessed by several biomarker measures, was highest in iqmik users, and similar in smokeless tobacco and cigarette smokers. TSNA exposure was highest in smokeless tobacco users, and polycyclic aromatic hydrocarbon exposure was highest in cigarette smokers.
Conclusions: Despite smoking fewer cigarettes per day, AN cigarette smokers had similar daily intake of nicotine compared to the general U.S. population. Nicotine exposure was greatest from iqmik, likely related to its high pH due to preparation with ash, suggesting high addiction potential compared to other smokeless tobacco products. TSNA exposure was much higher with smokeless tobacco than other product use, possibly contributing to the high rates of oral cancer.
Impact: Our data contribute to an understanding of the high addiction risk of iqmik use and of the cancer-causing potential of various forms of tobacco use among AN people.
Conflict of interest statement
R.F. Tyndale has honoraria from speakers’ bureau for CPT associate editor, has ownership interest (including patents) for Nicogen research, and is the consultant/advisory board member for Novartis and McNeil. The findings and conclusions of this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. No potential conflicts of interest were disclosed by other authors.
Figures
References
-
- Alaska Native Tribal Health Consortium. Alaska Native Health Status Report. Alaska: Alaska Native Epidemiology Center; 2009. [cited 2009 Mar 23]. Available from: http://www.anthc.org/chs/epicenter/upload/ANHSR.pdf.
-
- Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, et al. Iqmik: a form of smokeless tobacco used among Alaska natives. Am J Health Behav. 2005;29:588–94. - PubMed
-
- Department of Health and Human Services PHS. Tobacco use among U.S. racial/ethnic minority groups, African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: a report of the Surgeon General (Executive Summary) USDHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Promotion, Office of Smoking and Health; Washington, DC: Government Printing Office; 1998. - PubMed
-
- Centers for Disease Control and Prevention (CDC) Annual smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 1997–2001. MMWR Morb Mortal Wkly Rep. 2005;54:625–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
